Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
10.02
-0.32 (-3.09%)
At close: Nov 10, 2026, 4:00 PM EST
9.54
-0.48 (-4.78%)
Pre-market: Nov 11, 2026, 7:17 AM EST

Biodesix Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Biodesix stock has a consensus rating of "Strong Buy" and an average price target of $33.83. The average 1-year stock price forecast is 237.62% higher than the current stock price, while the lowest is $30 (+199.40%) and the highest is $40 (+299.20%).

Price Target: $33.83 (+237.62%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$30$33.83$34$40
Change+199.40%+237.62%+239.32%+299.20%

Analyst Ratings

The average analyst rating for Biodesix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy577777
Buy000000
Hold000000
Sell000000
Strong Sell000000
Total577777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$38 → $34
BuyReiterates$38 → $34+239.32%Nov 9, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Reiterates
$35
BuyReiterates$35+249.30%Nov 6, 2026
Roth MKM
Roth MKM
Buy
Maintains
$41 → $30
BuyMaintains$41 → $30+199.40%Nov 6, 2026
Lake Street
Lake Street
Buy
Maintains
$40 → $30
BuyMaintains$40 → $30+199.40%Nov 6, 2026
TD Cowen
TD Cowen
Buy
Maintains
$40 → $34
BuyMaintains$40 → $34+239.32%Nov 6, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
111.82M
from 88.50M
Increased by 26.35%
Revenue Next Year
134.63M
from 111.82M
Increased by 20.40%
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
54.51M38.21M49.09M71.32M88.50M111.82M
Revenue Growth
19.64%-29.89%28.46%45.30%24.08%26.35%
Gross Profit
23.99M24.06M36.08M55.75M71.78M91.00M
Gross Margin
44.01%62.96%73.50%78.17%81.11%81.38%
Operating Income
-39.32M-50.51M-41.30M-34.26M-27.77M-21.50M
Net Income
-43.16M-65.45M-52.15M-42.93M-35.27M-29.47M
Free Cash Flow
-----23.53M-7.90M
No. Analysts
-----7

Revenue Forecast

Revenue202620272028
High113.1M
Avg111.8M
Low111.0M

Revenue Growth

Revenue Growth202620272028
High
27.8%
Avg
26.3%
Low
25.4%

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-